Aura Biosciences, Inc.
- AURA
- NASDAQ
- Biotechnology
- Virus-Like Drug Conjugates
- Oncology (Cancer Therapies)
$6.10
Today −3.79%Quote Oct 16, 2026, 08:00 PM UTC
−7.44%over the last month
Max drawdown −9.0%From 1-month high −7.4%3 months −10.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$632.6M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$17.50
+186.9% from here
Floor
$5.93
2.8% below price
Where the price sits
8 analysts
Analyst range, low to high
$17.00$18.00
- Price $6.10
- Resistance $6.16
- Consensus $17.50
The price is right under resistance. Analysts' average target sits about 187% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AURAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
113